Othmar G Engelhardt (Othmar Engelhardt)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Pseudomonas Aeruginosa

Coronavirus Disease

Endothelial Cells

Top Venues

Influenza and other respiratory viruses

This page only lists publications with an associated author ORCID identifier.

Publications

Chung Y Cheung, Sitara Dubey, Martina Hadrovic, Christina R Ball, Walter Ramage, Jacqueline U McDonald, Ruth Harvey, Simon E Hufton, Othmar G Engelhardt
Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies. Vaccines 10 (9) (2022)
Andrew Tung Yep, Yasu Takeuchi, Othmar G Engelhardt, Simon E Hufton
Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy. Biomolecules 11 (3) (2021)
Beatriz Vidaña, Sharon M Brookes, Helen E Everett, Fanny Garcon, Alejandro Nuñez, Othmar G Engelhardt, Diane Major, Katja Hoschler, Ian H Brown, Maria Zambon
Inactivated pandemic 2009 H1N1 influenza A virus human vaccines have different efficacy after homologous challenge in the ferret model. Influenza and other respiratory viruses 15 (1) (2020)
Li-Mei Chen, Ruben O Donis, David L Suarez, David E Wentworth, Richard John Webby, Othmar G Engelhardt, David E Swayne
Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses. Influenza and other respiratory viruses 14 (2) (2019)
Florian Krammer, Jerry P Weir, Othmar G Engelhardt, Jacqueline M Katz, Rebecca Jane Cox
Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines. Influenza and other respiratory viruses 14 (2) (2019)
Sophia Pavlova, Flavia D'Alessio, Sophie Houard, Edmond J Remarque, Norbert Stockhofe, Othmar G Engelhardt
Workshop report: Immunoassay standardisation for "universal" influenza vaccines. Influenza and other respiratory viruses 11 (3) (2017)